Diagnosis and classification of hematologic malignancies on the basis of genetics

J Taylor, W **ao, O Abdel-Wahab - Blood, The Journal of the …, 2017 - ashpublications.org
Genomic analysis has greatly influenced the diagnosis and clinical management of patients
affected by diverse forms of hematologic malignancies. Here, we review how genetic …

Immunohistochemistry innovations for diagnosis and tissue-based biomarker detection

N Sukswai, JD Khoury - Current hematologic malignancy reports, 2019 - Springer
Abstract Purpose of Review Immunohistochemistry is an integral technique for tissue-based
diagnostics and biomarker detection with broad worldwide adoption. Advances in core …

JNK, p38, ERK, and SGK1 inhibitors in cancer

J Cicenas, E Zalyte, A Rimkus, D Dapkus, R Noreika… - Cancers, 2017 - mdpi.com
Mitogen-activated protein kinases (MAP kinases) are a family of kinases that regulates a
range of biological processes implicated in the response to growth factors like latelet …

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

F Behling, A Barrantes-Freer, M Skardelly, M Nieser… - Diagnostic …, 2016 - Springer
Background Treatment options for oncological diseases have been enhanced by the advent
of targeted therapies. The point mutation of the BRAF gene at codon 600 (BRAF V600E) is …

Molecular biomarkers for melanoma screening, diagnosis and prognosis: current state and future prospects

DC Deacon, EA Smith, RL Judson-Torres - Frontiers in Medicine, 2021 - frontiersin.org
Despite significant progress in the development of treatment options, melanoma remains a
leading cause of death due to skin cancer. Advances in our understanding of the genetic …

Simplified methods for identifying subtypes of automatically maintained self‐injury

LP Hagopian, JM Falligant… - Journal of applied …, 2023 - Wiley Online Library
Subtypes of automatically maintained self‐injurious behavior (SIB) have been defined
based on response patterns observed during the functional analysis, which are thought to …

[HTML][HTML] Vulvar malignant melanoma: a narrative review

G Falcicchio, L Vinci, E Cicinelli, V Loizzi, F Arezzo… - Cancers, 2022 - mdpi.com
Simple Summary Vulvar melanoma (VM) is a rare and fatal disease. Knowledge of this
disease is poor and, consequently, so is knowledge of the prognosis. Our aim was to collect …

Pathology of melanotic schwannoma

BA Alexiev, PM Chou… - Archives of Pathology & …, 2018 - meridian.allenpress.com
Context.—Melanotic schwannoma (MS) is a nerve sheath tumor with a uniform composition
of variably melanin-producing Schwann cells and metastatic potential. The MS is an …

Evolution of the targeted therapy landscape for cholangiocarcinoma: Is cholangiocarcinoma the 'NSCLC'of GI oncology?

A Gupta, R Kurzrock, JJ Adashek - Cancers, 2023 - mdpi.com
Simple Summary In the past 20 years, the development of targeted therapies that can be
matched to a tumor's molecular and immune abnormalities has resulted in the improvement …

BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival

E Hugdahl, MB Kalvenes, HE Puntervoll… - British journal of …, 2016 - nature.com
Background: Around 50% of primary melanomas harbour BRAF mutations, but their
prognostic impact has not been clear. Recently, a BRAF-V600E mutation-specific antibody …